Allworth Financial’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $632K | Buy |
1,167
+84
| +8% | +$47.3K | ﹤0.01% | 893 |
|
|
2026
Q1 | $642K | Buy |
1,083
+113
| +12% | +$56.3K | ﹤0.01% | 855 |
|
|
2025
Q4 | $473K | Buy |
970
+521
| +116% | +$243K | ﹤0.01% | 954 |
|
|
2025
Q3 | $188K | Buy |
449
+93
| +26% | +$31.3K | ﹤0.01% | 1332 |
|
|
2025
Q2 | $102K | Buy |
356
+212
| +147% | +$63.4K | ﹤0.01% | 1542 |
|
|
2025
Q1 | $42.7K | Buy |
144
+22
| +18% | +$7.54K | ﹤0.01% | 1635 |
|
|
2024
Q4 | $45.3K | Buy |
122
+8
| +7% | +$2.94K | ﹤0.01% | 1626 |
|
|
2024
Q3 | $40.9K | Sell |
114
-33
| -22% | -$11.1K | ﹤0.01% | 1500 |
|
|
2024
Q2 | $48.4K | Buy |
147
+39
| +36% | +$10.3K | ﹤0.01% | 1403 |
|
|
2024
Q1 | $24.8K | Buy |
108
+21
| +24% | +$4.74K | ﹤0.01% | 1647 |
|
|
2023
Q4 | $19.1K | Buy |
87
+2
| +2% | +$461 | ﹤0.01% | 1676 |
|
|
2023
Q3 | $19.2K | Buy |
85
+3
| +4% | +$691 | ﹤0.01% | 1542 |
|
|
2023
Q2 | $18.1K | Buy |
82
+71
| +645% | +$15.7K | ﹤0.01% | 1599 |
|
|
2023
Q1 | $2.46K | Buy |
11
+10
| +1,000% | +$2.46K | ﹤0.01% | 2323 |
|
|
2022
Q4 | $278 | Sell |
1
-4
| -80% | -$1.01K | ﹤0.01% | 2739 |
|
|
2022
Q3 | $1K | Buy |
5
+4
| +400% | +$894 | ﹤0.01% | 2531 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2836 |
|
|
2022
Q1 | $0 | Sell |
1
-43
| -98% | -$8.19K | ﹤0.01% | 2399 |
|
|
2021
Q4 | $10K | Buy |
+44
| New | +$8.64K | ﹤0.01% | 1388 |
|
|
2020
Q2 | – | Sell |
-50
| Closed | -$5K | – | 1382 |
|
|
2020
Q1 | $5K | Hold |
50
| – | – | ﹤0.01% | 887 |
|
|
2019
Q4 | $4K | Hold |
50
| – | – | ﹤0.01% | 818 |
|
|
2019
Q3 | $4K | Hold |
50
| – | – | ﹤0.01% | 730 |
|
|
2019
Q2 | $4K | Hold |
50
| – | – | ﹤0.01% | 720 |
|
|
2019
Q1 | $6K | Hold |
50
| – | – | ﹤0.01% | 658 |
|
|
2018
Q4 | $5K | Hold |
50
| – | – | ﹤0.01% | 623 |
|
|
2018
Q3 | $6K | Hold |
50
| – | – | ﹤0.01% | 646 |
|
|
2018
Q2 | $6K | Hold |
50
| – | – | ﹤0.01% | 611 |
|
|
2018
Q1 | $6K | Hold |
50
| – | – | ﹤0.01% | 570 |
|
|
2017
Q4 | $7K | Hold |
50
| – | – | ﹤0.01% | 527 |
|
|
2017
Q3 | $6K | Hold |
50
| – | – | ﹤0.01% | 558 |
|
|
2017
Q2 | $6K | Hold |
50
| – | – | ﹤0.01% | 555 |
|
|
2017
Q1 | $7K | Hold |
50
| – | – | ﹤0.01% | 494 |
|
|
2016
Q4 | $7K | Hold |
50
| – | – | ﹤0.01% | 449 |
|
|
2016
Q3 | $6K | Hold |
50
| – | – | ﹤0.01% | 478 |
|
|
2016
Q2 | $5K | Hold |
50
| – | – | ﹤0.01% | 469 |
|
|
2016
Q1 | $6K | Hold |
50
| – | – | ﹤0.01% | 435 |
|
|
2015
Q4 | $8K | Hold |
50
| – | – | ﹤0.01% | 403 |
|
|
2015
Q3 | $7K | Hold |
50
| – | – | ﹤0.01% | 420 |
|
|
2015
Q2 | $9K | Hold |
50
| – | – | ﹤0.01% | 396 |
|
|
2015
Q1 | $9K | Buy |
+50
| New | +$7.62K | ﹤0.01% | 405 |
|
Other funds holding UTHR
ACA
JT
Allworth Financial's UTHR Position: Q2 2026 in Review
Allworth Financial increased its United Therapeutics (UTHR) stake by 7.8% in Q2 2026, buying an estimated $47.3K and bringing the position to 1,167 shares worth $632K. The position accounts for ﹤0.01% of the portfolio, ranked #893.
Allworth Financial first reported a position in UTHR in Q1 2015 and has held it in 40 quarters since. The position peaked at $642K in Q1 2026. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Allworth Financial held 1,167 shares of United Therapeutics worth $632K as of Q2 2026.
- Allworth Financial bought 84 United Therapeutics shares in Q2 2026, an estimated $47.3K.
- United Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #893 holding.
- Allworth Financial first reported a position in United Therapeutics in Q1 2015 and has held it in 40 quarters since.
- Allworth Financial's United Therapeutics position peaked at $642K in Q1 2026.
- 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.